222 related articles for article (PubMed ID: 36806762)
21. Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study.
Iwata Y; Nakajima S; Plitman E; Caravaggio F; Kim J; Shah P; Mar W; Chavez S; De Luca V; Mimura M; Remington G; Gerretsen P; Graff-Guerrero A
Biol Psychiatry; 2019 Apr; 85(7):596-605. PubMed ID: 30389132
[TBL] [Abstract][Full Text] [Related]
22. Using proton magnetic resonance spectroscopic imaging to study glutamatergic alterations in patients with schizophrenia: A systematic review.
Plitman E; Guma E; Lepage M; Near J; Chakravarty MM
Schizophr Res; 2019 Aug; 210():13-20. PubMed ID: 31272905
[TBL] [Abstract][Full Text] [Related]
23. The impact of endurance training and table soccer on brain metabolites in schizophrenia.
Rauchmann BS; Ghaseminejad F; Keeser D; Keller-Varady K; Schneider-Axmann T; Takahashi S; Karali T; Helms G; Dechent P; Maurus I; Hasan A; Wobrock T; Ertl-Wagner B; Schmitt A; Malchow B; Falkai P
Brain Imaging Behav; 2020 Apr; 14(2):515-526. PubMed ID: 31686308
[TBL] [Abstract][Full Text] [Related]
24. Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study.
Tarumi R; Tsugawa S; Noda Y; Plitman E; Honda S; Matsushita K; Chavez S; Sawada K; Wada M; Matsui M; Fujii S; Miyazaki T; Chakravarty MM; Uchida H; Remington G; Graff-Guerrero A; Mimura M; Nakajima S
Neuropsychopharmacology; 2020 Mar; 45(4):632-640. PubMed ID: 31842203
[TBL] [Abstract][Full Text] [Related]
25. Increased glutamine in patients undergoing long-term treatment for schizophrenia: a proton magnetic resonance spectroscopy study at 3 T.
Bustillo JR; Chen H; Jones T; Lemke N; Abbott C; Qualls C; Canive J; Gasparovic C
JAMA Psychiatry; 2014 Mar; 71(3):265-72. PubMed ID: 24402128
[TBL] [Abstract][Full Text] [Related]
26. Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies.
Marsman A; van den Heuvel MP; Klomp DW; Kahn RS; Luijten PR; Hulshoff Pol HE
Schizophr Bull; 2013 Jan; 39(1):120-9. PubMed ID: 21746807
[TBL] [Abstract][Full Text] [Related]
27. Glutamatergic function in a genetic high-risk group for psychosis: A proton magnetic resonance spectroscopy study in individuals with 22q11.2 deletion.
Rogdaki M; Hathway P; Gudbrandsen M; McCutcheon RA; Jauhar S; Daly E; Howes O
Eur Neuropsychopharmacol; 2019 Dec; 29(12):1333-1342. PubMed ID: 31648854
[TBL] [Abstract][Full Text] [Related]
28. Choline Compounds of the Frontal Lobe and Temporal Glutamatergic System in Bipolar and Schizophrenia Proton Magnetic Resonance Spectroscopy Study.
Galińska-Skok B; Małus A; Konarzewska B; Rogowska-Zach A; Milewski R; Tarasów E; Szulc A; Waszkiewicz N
Dis Markers; 2018; 2018():3654894. PubMed ID: 30595760
[TBL] [Abstract][Full Text] [Related]
29. Reduced
Wang J; Tang Y; Zhang T; Cui H; Xu L; Zeng B; Li Y; Li G; Li C; Liu H; Lu Z; Zhang J; Wang J
Neural Plast; 2016; 2016():3915703. PubMed ID: 28003912
[TBL] [Abstract][Full Text] [Related]
30. Medial Prefrontal Cortex Glutamate Is Reduced in Schizophrenia and Moderated by Measurement Quality: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.
Smucny J; Carter CS; Maddock RJ
Biol Psychiatry; 2021 Nov; 90(9):643-651. PubMed ID: 34344534
[TBL] [Abstract][Full Text] [Related]
31. Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.
de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Solís-Vivanco R; Favila R; Graff-Guerrero A; Shungu DC
Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv105. PubMed ID: 26364273
[TBL] [Abstract][Full Text] [Related]
32. Functional magnetic resonance spectroscopy in patients with schizophrenia and bipolar affective disorder: Glutamate dynamics in the anterior cingulate cortex during a working memory task.
Jelen LA; King S; Horne CM; Lythgoe DJ; Young AH; Stone JM
Eur Neuropsychopharmacol; 2019 Dec; 29(2):222-234. PubMed ID: 30558824
[TBL] [Abstract][Full Text] [Related]
33. Treatment effects on neurometabolite levels in schizophrenia: A systematic review and meta-analysis of proton magnetic resonance spectroscopy studies.
Kubota M; Moriguchi S; Takahata K; Nakajima S; Horita N
Schizophr Res; 2020 Aug; 222():122-132. PubMed ID: 32505446
[TBL] [Abstract][Full Text] [Related]
34. Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [¹H]MRS study.
Horder J; Lavender T; Mendez MA; O'Gorman R; Daly E; Craig MC; Lythgoe DJ; Barker GJ; Murphy DG
Transl Psychiatry; 2013 Jul; 3(7):e279. PubMed ID: 23838890
[TBL] [Abstract][Full Text] [Related]
35. Glutamate/glutamine and neuronal integrity in adults with ADHD: a proton MRS study.
Maltezos S; Horder J; Coghlan S; Skirrow C; O'Gorman R; Lavender TJ; Mendez MA; Mehta M; Daly E; Xenitidis K; Paliokosta E; Spain D; Pitts M; Asherson P; Lythgoe DJ; Barker GJ; Murphy DG
Transl Psychiatry; 2014 Mar; 4(3):e373. PubMed ID: 24643164
[TBL] [Abstract][Full Text] [Related]
36. Brain glutamate in medication-free depressed patients: a proton MRS study at 7 Tesla.
Godlewska BR; Masaki C; Sharpley AL; Cowen PJ; Emir UE
Psychol Med; 2018 Jul; 48(10):1731-1737. PubMed ID: 29224573
[TBL] [Abstract][Full Text] [Related]
37. Glutamatergic neurotransmission in schizophrenia: A systematic review and quantitative synthesis of proton magnetic resonance spectroscopy studies across schizophrenia spectrum disorders.
Lopes JJ; Carruthers SP; Meyer D; Dean B; Rossell SL
Aust N Z J Psychiatry; 2024 May; ():48674241254216. PubMed ID: 38812258
[TBL] [Abstract][Full Text] [Related]
38. Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla.
Bustillo JR; Chen H; Gasparovic C; Mullins P; Caprihan A; Qualls C; Apfeldorf W; Lauriello J; Posse S
Biol Psychiatry; 2011 Jan; 69(1):19-27. PubMed ID: 20970118
[TBL] [Abstract][Full Text] [Related]
39. Abnormal neurobiochemical metabolites in the first
Ouyang L; Zheng W; Ma X; Yuan L; He Y; Chen X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 46(10):1090-1095. PubMed ID: 34911838
[TBL] [Abstract][Full Text] [Related]
40. Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Spitzberg K; Kersting A; Arolt V; Heindel W; Pfleiderer B
Schizophr Res; 2005 Mar; 73(2-3):153-7. PubMed ID: 15653258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
